photobyphm / Shutterstock.com
India’s Delhi High Court has dismissed a petition for an injunction by German pharma company Bayer against an Indian competitor.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Natco Pharma, Bayer, India Delhi High Court, patent infringement, generics, colorectal cancer, Regorafenib